| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | 0.091 | 0.03 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.03 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.099 | 0.03 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | 0.082 | 0.03 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | 0.2 | 0.03 |
| mRNA | NU-7441 | GDSC1000 | pan-cancer | AAC | 0.082 | 0.03 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.03 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.1 | 0.03 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.097 | 0.03 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | -0.079 | 0.03 |